4 April 2009

New study confirms Prana’s PBT2 drug strategy

Independent study corroborates Prana's strategy to treat Alzheimer’s disease patients
Prana: 2 April 2009
Prana Biotechnology announced that an independent study conducted by researchers at the University of California, Irvine, validates Prana's fundamental drug strategy for Alzheimer's Disease in blocking the toxic interaction between Abeta and brain metals, such as zinc, that damages synapses and cause cognitive loss. … > full story : UC Irvine press release

No comments:

Post a Comment

Alzheimer's Australia NSW

Alzheimer's Australia NSW
Alzheimer's Australia NSW

Latest headlines from Library News

Library News

Total Pageviews